In Hadisson Akhar, Ricardo has again engaged with high-level Arab achievers from across the world in the fields of science, medicine, business, politics and philanthropy. Those were the men and women who would normally shun the spotlight in order to get on with the business of ‘saving the world’ or ‘building an empire’. Without Ricardo’s persistence, many of their stories would never be told. Yet these people are among the unsung heroes of the 21st century, outstanding role models for future generations to come.
Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent), a publicly traded biopharmaceutical company focused on developing, manufacturing and commercializing vaccines and antibody therapies to prevent or treat diseases. As well as producing the only licensed vaccine against anthrax, Emergent’s product pipeline focuses on tuberculosis, flu, and Chlamydia.
El-Hibri has extensive experience in the biopharmaceutical industry beginning with Porton Products, Ltd. (Porton), a mid-sized biotechnology company in the United Kingdom. His previous successes include forming and then selling three mobile telecommunications companies, Mobile TeleSystems, serving the Moscow region, and Digitel and Digicel, serving markets in South and Central America. El-Hibri began his career as a commercial banker with Citigroup, followed by Booz Allen & Hamilton where he worked as a management consultant in South East Asia.
Born to a Lebanese father and a German Mother, Fuad El-Hibri is active in a variety of not-for-profit, academic, and other community-based organizations both in the United States and internationally. These include as a member of the Board of Trustees of The International Biomedical Research Alliance, and The National Health Museum; the Advisory Board of the Heifetz International Music Institute and Chairman of The El-Hibri Charitable Foundation a nonprofit organization dedicated to fostering interfaith collaboration, cultural understanding and humanitarian programs.